Visa (V) Share Value Rose While Bluespruce Investments LP Has Decreased Holding; Abbvie (ABBV) Stake Has Increased by Harris Associates L P

January 16, 2018 - By Michael Collier

Harris Associates LP increased its stake in Abbvie Inc (ABBV) by 157.59% based on its latest 2017Q3 regulatory filing with the SEC. Harris Associates LP bought 37,350 shares as the company’s stock rose 6.17% with the market. The hedge fund held 61,050 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $5.43 million, up from 23,700 at the end of the previous reported quarter. Harris Associates LP who had been investing in Abbvie Inc for a number of months, seems to be bullish on the $164.21B market cap company. The stock increased 2.51% or $2.52 during the last trading session, reaching $102.86. About 4.77 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since January 16, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.

Bluespruce Investments Lp decreased its stake in Visa Inc (V) by 9.58% based on its latest 2017Q3 regulatory filing with the SEC. Bluespruce Investments Lp sold 49,156 shares as the company’s stock rose 5.74% with the market. The hedge fund held 464,009 shares of the business services company at the end of 2017Q3, valued at $48.83 million, down from 513,165 at the end of the previous reported quarter. Bluespruce Investments Lp who had been investing in Visa Inc for a number of months, seems to be less bullish one the $273.08B market cap company. The stock increased 0.34% or $0.4116 during the last trading session, reaching $120.5016. About 6.25 million shares traded. Visa Inc. (NYSE:V) has risen 20.29% since January 16, 2017 and is uptrending. It has outperformed by 3.59% the S&P500.

Investors sentiment decreased to 1 in Q3 2017. Its down 0.13, from 1.13 in 2017Q2. It is negative, as 48 investors sold V shares while 617 reduced holdings. 142 funds opened positions while 524 raised stakes. 1.64 billion shares or 1.45% less from 1.66 billion shares in 2017Q2 were reported. Hbk Sorce Advisory Limited Company holds 0.32% or 20,058 shares. Moreover, Profund Limited Liability has 0.23% invested in Visa Inc. (NYSE:V) for 52,880 shares. Utd Retail Bank Inc owns 5,261 shares. Sands Llc reported 22.17 million shares. Godsey & Gibb owns 146,731 shares. 2,789 were accumulated by Thompson Davis Inc. Driehaus Cap Ltd Liability has invested 0.02% in Visa Inc. (NYSE:V). Cls Invs Limited Liability reported 16,627 shares or 0.06% of all its holdings. Troy Asset Mgmt Ltd owns 96,577 shares. Peddock Capital Advsr Ltd Liability Com stated it has 1,788 shares. Cue Fincl Gru Incorporated holds 1.41% in Visa Inc. (NYSE:V) or 19,228 shares. Plancorp Ltd Liability Co invested 0.08% in Visa Inc. (NYSE:V). Twin Tree Management Lp holds 2,212 shares. 3,564 were accumulated by Cwm Ltd Co. First Mercantile reported 32,142 shares.

Since August 17, 2017, it had 0 insider buys, and 3 selling transactions for $7.43 million activity. On Friday, December 15 MAHON TULLIER KELLY sold $5.65M worth of Visa Inc. (NYSE:V) or 49,702 shares. $707,561 worth of Visa Inc. (NYSE:V) was sold by MATSCHULLAT ROBERT W on Wednesday, December 13.

Among 40 analysts covering Visa Inc. (NYSE:V), 33 have Buy rating, 0 Sell and 7 Hold. Therefore 83% are positive. Visa Inc. had 102 analyst reports since July 21, 2015 according to SRatingsIntel. The company was maintained on Wednesday, August 23 by KeyBanc Capital Markets. The stock has “Buy” rating by RBC Capital Markets on Friday, September 22. The stock of Visa Inc. (NYSE:V) earned “Outperform” rating by RBC Capital Markets on Tuesday, November 3. Oppenheimer maintained it with “Buy” rating and $10000 target in Friday, June 23 report. The company was maintained on Friday, January 12 by Cowen & Co. The rating was maintained by Oppenheimer on Wednesday, October 25 with “Buy”. As per Thursday, October 8, the company rating was initiated by Guggenheim. The firm earned “Buy” rating on Thursday, June 22 by RBC Capital Markets. Stifel Nicolaus maintained Visa Inc. (NYSE:V) rating on Friday, February 3. Stifel Nicolaus has “Buy” rating and $105 target. The firm has “Outperform” rating given on Tuesday, October 25 by RBC Capital Markets.

Analysts await Visa Inc. (NYSE:V) to report earnings on February, 1. They expect $0.97 earnings per share, up 12.79% or $0.11 from last year’s $0.86 per share. V’s profit will be $2.20 billion for 31.06 P/E if the $0.97 EPS becomes a reality. After $0.90 actual earnings per share reported by Visa Inc. for the previous quarter, Wall Street now forecasts 7.78% EPS growth.

Bluespruce Investments Lp, which manages about $352.80 million and $530.54M US Long portfolio, upped its stake in Vantiv Inc (NYSE:VNTV) by 95,317 shares to 794,528 shares, valued at $55.99M in 2017Q3, according to the filing. It also increased its holding in Mohawk Industries Inc (NYSE:MHK) by 90,590 shares in the quarter, for a total of 97,952 shares, and has risen its stake in Class A.

Harris Associates L P, which manages about $59.29B US Long portfolio, decreased its stake in Grainger W W Inc (NYSE:GWW) by 18,566 shares to 98,618 shares, valued at $17.73 million in 2017Q3, according to the filing. It also reduced its holding in Borgwarner Inc (NYSE:BWA) by 859,200 shares in the quarter, leaving it with 5.76 million shares, and cut its stake in Jpmorgan Chase & Co (NYSE:JPM).

Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Abbvie Inc had 70 analyst reports since July 21, 2015 according to SRatingsIntel. Jefferies maintained it with “Buy” rating and $9000 target in Thursday, May 25 report. The firm earned “Buy” rating on Sunday, October 29 by SunTrust. The rating was downgraded by Barclays Capital to “Equal-Weight” on Tuesday, December 1. Morgan Stanley downgraded the stock to “Equal-Weight” rating in Wednesday, June 8 report. The rating was initiated by SunTrust on Wednesday, July 22 with “Buy”. The firm earned “Outperform” rating on Wednesday, October 11 by Cowen & Co. The stock has “Market Perform” rating by BMO Capital Markets on Thursday, November 16. The firm has “Hold” rating by BMO Capital Markets given on Wednesday, June 7. The stock of AbbVie Inc. (NYSE:ABBV) earned “Buy” rating by Jefferies on Friday, July 14. The rating was maintained by Leerink Swann with “Buy” on Tuesday, December 5.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: